[Federal Register Volume 66, Number 192 (Wednesday, October 3, 2001)]
[Notices]
[Page 50454]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-24642]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 16, 2001, Roche 
Diagnostics Corporation, Attn: Regulatory Compliance, 9115 Hague Road, 
Indianapolis, Indiana 46250, made application by letter to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of Alphamethadol (9605), a basic class of controlled 
substance listed in Schedule I.
    Roche Diagnostics Corporation plans to manufacture small quantities 
of the above listed controlled substances for incorporation in drug of 
abuse detection kits.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistance Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than December 3, 2001.

    Dated: September 24, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-24642 Filed 10-2-01; 8:45 am]
BILLING CODE 4410-09-M